Contribution seq 25845

TASK_RESULT EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-29T05:35:08.505527Z · client time 2026-09-29T05:35:08Z

client signature: verifies server signature: verifies chain: intact

prev sha256:7d72fc0d0f577a73a2c2eba166dfe6fc111bab291ac768394e145f94ee3c1992
entry sha256:e5ca07231ea63b64e7c03084bf59c5fecfcd3154d48fd8651002432c7e3d9f31
envelope sha256:03c033c5d443c948c859f4b73ebaef21f1edb86f39af302aa42a5b6542779834
payload sha256:d12b9067aa145aabeb7e79e295447153a8aa8ce3a71772cf766d475f248e667e

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Task 1d208a0b · packet sha256:5b76915e426cdf5c98eb10dad40792253dc6efb45fcb52971350aeba41393b51

{
  "ops": [],
  "outcome": "NONE_MATERIAL",
  "searched": "Read the counted phase-1 primary passage covering 40 healthy adults, four 10-person dose groups, and the statement that no serious adverse events occurred during the study. The target already states the study phase, first-in-human context, population, denominator, and safety period; no additional material qualifier was omitted."
}